<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03556189</url>
  </required_header>
  <id_info>
    <org_study_id>AV delay</org_study_id>
    <nct_id>NCT03556189</nct_id>
  </id_info>
  <brief_title>Atrioventricular Optimization for Dual Chamber Pacemaker</brief_title>
  <official_title>Effect of Atrioventricular Optimization on Left Ventricular Function With Dual Chamber Pacemaker; Prospective Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yong Seog Oh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul St. Mary's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the effect of atrioventricular synchrony in AV block patients who
      received permanent pacemaker. By achieving physiologic ventricular diastolic filling,
      adjustment of atrioventricular delay of pacemaker might affect the long term outcome of left
      ventricular function and remodelling. The investigators designed to randomize AV block
      patients who already have or anticipated to receive pacemaker, into two groups. Patients in
      intervention group undergo reprogramming AV delay of pacemaker to the best value to increase
      cardiac output measured by transthoracic echocardiogram and the patients in control group
      undergo routinely scheduled pacemaker programming. The primary endpoint is improvement of LV
      systolic function and the secondary endpoint is change in left ventricular volume, cardiac
      output, BNP, 6-minute walk capacity and NYHA class after one year.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is well-known that persistent right ventricular apical pacing induces left ventricular
      dysfunction. The most important risk factor is the ratio of ventricular pacing so the effort
      to reduce pacing ratio is needed. However, almost 100% ventricular pacing is inevitable in
      complete atrio-ventricular block patients with implanted pacemaker. Traditionally the
      ventricular lead of the pacemaker is positioned in right ventricular apex and previous
      literatures reported that such right ventricular apical pacing impedes physiological
      ventricular contraction and induces left ventricular contractile dysfunction in long-term.
      The alternative positions of ventricular lead are right ventricular outflow tract and
      ventricular septum but the benefits are not yet clearly prooved. Additionally, adjusting
      atrio-ventricular delay is reportedto affect cardiac output by altering diastolic filling.
      The investigators aimed to analyze the effect of AV dealy in long-term left ventricular
      contractile function.

      Patients over 19 years old who received or anticipated to receive permanent pacemaker due to
      AV block are randomized to 1:1 ratio into two groups. Patients in intervention group undergo
      reprogramming AV delay of pacemaker to the best value to increase cardiac output measured by
      transthoracic echocardiogram and the patients in control group undergo routinely scheduled
      pacemaker programming. Patients with underlying LV systolic dysfunction or significant
      valvular heart disease are excluded. Six-minute walk test, BNP, transthoracic echocardiogram,
      NYHA class are examined at baseline and after one year.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>one year after randomization</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-diastolic diameter</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular end-systolic diameter</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cardiac output</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BNP</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walking test</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>one year after randomization</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>AV Block</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>case management consists adjusting AV delay of pacemaker to achieve best cardiac output measured by trans-thoracic echocardiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control: Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual care is provided with routine pacemaker interrogation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Case management</intervention_name>
    <description>Case management consists adjusting AV delay of pacemaker to achieve best cardiac output measured by trans-thoracic echocardiogram</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Received or scheduled to receive permanent pacemaker due to AV block

        Exclusion Criteria:

          -  Left ventricular ejection fraction &lt;50% or Left ventricular end-diastolic
             diameter&gt;60mm Significant valvular disease (â‰¥mild)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yong-Seog Oh, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yong-Seog Oh, MD,PhD</last_name>
    <phone>82-2-2258-6035</phone>
    <email>oys@catholic.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ju Youn Kim, MD</last_name>
    <phone>82-10-5482-7307</phone>
    <email>zzoo921@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seo Ch-gu</state>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ju Youn Kim, MD</last_name>
      <phone>82-10-5482-7307</phone>
      <email>zzoo921@catholic.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Yong Seog Oh, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>April 24, 2017</study_first_submitted>
  <study_first_submitted_qc>June 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 14, 2018</study_first_posted>
  <last_update_submitted>June 3, 2018</last_update_submitted>
  <last_update_submitted_qc>June 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Seoul St. Mary's Hospital</investigator_affiliation>
    <investigator_full_name>Yong Seog Oh</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrioventricular Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

